The microbiota in inflammatory bowel disease: current and therapeutic insights

References

• MiyoshiJChangEBThe gut microbiota and inflammatory bowel diseasesTransl Res2017179384827371886
   PubMed Web of Science ®Google Scholar
• LoftusEVJrClinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influencesGastroenterology200412661504151715168363
   PubMed Web of Science ®Google Scholar
• MolodeckyNASoonISRabiDMIncreasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic reviewGastroenterology201214214654e42 quiz e3022001864
   PubMed Web of Science ®Google Scholar
• AnanthakrishnanANKhaliliHKonijetiGGA prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitisGastroenterology2013145597097723912083
   PubMed Web of Science ®Google Scholar
• PonderALongMDA clinical review of recent findings in the epidemiology of inflammatory bowel diseaseClinEpidemiol20135237247
   Google Scholar
• KosticADXavierRJGeversDThe microbiome in inflammatory bowel disease: current status and the future aheadGastroenterology201414661489149924560869
   PubMed Web of Science ®Google Scholar
• HalmeLPaavola-SakkiPTurunenULappalainenMFarkkilaMKontulaKFamily and twin studies in inflammatory bowel diseaseWorld J Gastroenterol200612233668367216773682
   PubMed Web of Science ®Google Scholar
• YazdanyarSKamstrupPRTybjaerg-HansenANordestgaardBGPenetrance of NOD2/CARD15 genetic variants in the general populationCMAJ2010182766166520371648
   PubMed Web of Science ®Google Scholar
• HansenJJSartorRBTherapeutic manipulation of the microbiome in IBD: current results and future approachesCurr Treat Options Gastroenterol201513110512025595930
   PubMedGoogle Scholar
• FrankDNRobertsonCEHammCMDisease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseasesInflamm Bowel Dis201117117918420839241
   PubMed Web of Science ®Google Scholar
• MorganXCTickleTLSokolHDysfunction of the intestinal microbiome in inflammatory bowel disease and treatmentGenome Biol2012139R7923013615
   PubMed Web of Science ®Google Scholar
• LiJButcherJMackDStintziAFunctional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel diseaseInflamm Bowel Dis201521113915325248007
   PubMed Web of Science ®Google Scholar
• GeversDKugathasanSDensonLAThe treatment-naive microbiome in new-onset Crohn’s diseaseCell Host Microbe201415338239224629344
   PubMed Web of Science ®Google Scholar
• FrankDNSt AmandALFeldmanRABoedekerECHarpazNPaceNRMolecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesProcNatlAcadSci U S A2007104341378013785
   PubMed Web of Science ®Google Scholar
• OttSJMusfeldtMWenderothDFReduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel diseaseGut200453568569315082587
   PubMed Web of Science ®Google Scholar
• ManichanhCRigottier-GoisLBonnaudEReduced diversity of faecalmicrobiota in Crohn’s disease revealed by a metagenomic approachGut200655220521116188921
   PubMed Web of Science ®Google Scholar
• FicheraAMcCormackRRubinMAHurstRDMichelassiFLong-term outcome of surgically treated Crohn’s colitis: a prospective studyDis Colon Rectum200548596396915785882
   PubMed Web of Science ®Google Scholar
• LeeYKMazmanianSKHas the microbiota played a critical role in the evolution of the adaptive immune system?Science201033060121768177321205662
   PubMed Web of Science ®Google Scholar
• JostinsLRipkeSWeersmaRKHost-microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature2012491742211912423128233
   PubMed Web of Science ®Google Scholar
• McGovernDPJonesMRTaylorKDInternational IBD Genetics ConsortiumFucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn’s diseaseHum Mol Genet201019173468347620570966
   PubMed Web of Science ®Google Scholar
• RauschPRehmanAKunzelSColonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotypeProcNatlAcadSci U S A2011108471903019035
   PubMed Web of Science ®Google Scholar
• ElinavEStrowigTKauALNLRP6 inflammasome regulates colonic microbial ecology and risk for colitisCell2011145574575721565393
   PubMed Web of Science ®Google Scholar
• DheerRSantaolallaRDaviesJMIntestinal epithelial toll-like receptor 4 signaling affects epithelial function and colonic microbiota and promotes a risk for transmissible colitisInfect Immun201684379881026755160
   PubMed Web of Science ®Google Scholar
• SartorRBTherapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebioticsGastroenterology200412661620163315168372
   PubMed Web of Science ®Google Scholar
• RietdijkSTD’HaensGRRecent developments in the treatment of inflammatory bowel diseaseJ Dig Dis201314628228723419117
   PubMed Web of Science ®Google Scholar
• PerencevichMBurakoffRUse of antibiotics in the treatment of inflammatory bowel diseaseInflamm Bowel Dis200612765166416804403
   PubMed Web of Science ®Google Scholar
• SalehMTrinchieriGInnate immune mechanisms of colitis and colitis-associated colorectal cancerNat Rev Immunol201111192021151034
   PubMed Web of Science ®Google Scholar
• KennedyRJHoperMDeodharKErwinPJKirkSJGardinerKRInterleukin 10-deficient colitis: new similarities to human inflammatory bowel diseaseBr J Surg200087101346135111044159
   PubMed Web of Science ®Google Scholar
• Human Microbiome Project CStructure, function and diversity of the healthy human microbiomeNature2012486740220721422699609
   PubMed Web of Science ®Google Scholar
• DaveMHigginsPDMiddhaSRiouxKPThe human gut microbiome: current knowledge, challenges, and future directionsTransl Res2012160424625722683238
   PubMed Web of Science ®Google Scholar
• QinJLiRRaesJA human gut microbial gene catalogue established by metagenomic sequencingNature20104647285596520203603
   PubMed Web of Science ®Google Scholar
• EckburgPBBikEMBernsteinCNDiversity of the human intestinal microbial floraScience200530857281635163815831718
   PubMed Web of Science ®Google Scholar
• ClaessonMJJefferyIBCondeSGut microbiota composition correlates with diet and health in the elderlyNature2012488741017818422797518
   PubMed Web of Science ®Google Scholar
• Dominguez-BelloMGBlaserMJLeyREKnightRDevelopment of the human gastrointestinal microbiota and insights from high-throughput sequencingGastroenterology201114061713171921530737
   PubMed Web of Science ®Google Scholar
• YatsunenkoTReyFEManaryMJHuman gut microbiome viewed across age and geographyNature2012486740222222722699611
   PubMed Web of Science ®Google Scholar
• LimESZhouYZhaoGEarly life dynamics of the human gut virome and bacterial microbiome in infantsNat Med201521101228123426366711
   PubMed Web of Science ®Google Scholar
• JakobssonHEAbrahamssonTRJenmalmMCDecreased gut microbiota diversity, delayed Bacteroidetescolonisation and reduced Th1 responses in infants delivered by caesarean sectionGut201463455956623926244
   PubMed Web of Science ®Google Scholar
• BagerPSimonsenJNielsenNMFrischMCesarean section and offspring’s risk of inflammatory bowel disease: a national cohort studyInflamm Bowel Dis201218585786221739532
   PubMed Web of Science ®Google Scholar
• BernsteinCNBanerjeeATargownikLECesarean section delivery is not a risk factor for development of inflammatory bowel disease: apopulation-based analysisClinGastroenterolHepatol20161415057
   Google Scholar
• BezirtzoglouETsiotsiasAWellingGWMicrobiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH)Anaerobe201117647848221497661
   PubMed Web of Science ®Google Scholar
• PendersJThijsCVinkCFactors influencing the composition of the intestinal microbiota in early infancyPediatrics2006118251152116882802
   PubMed Web of Science ®Google Scholar
• PraveenPJordanFPriamiCMorineMJThe role of breast-feeding in infant immune system: a systems perspective on the intestinal microbiomeMicrobiome201534126399409
   PubMed Web of Science ®Google Scholar
• BarclayARRussellRKWilsonMLGilmourWHSatsangiJWilsonDCSystematic review: the role of breastfeeding in the development of pediatric inflammatory bowel diseaseJ Pediatr2009155342142619464699
   PubMed Web of Science ®Google Scholar
• BackhedFRoswallJPengYDynamics and stabilization of the human gut microbiome during the first year of lifeCell Host Microbe201517569070325974306
   PubMed Web of Science ®Google Scholar
• PlanerJDPengYKauALDevelopment of the gut microbiota and mucosal IgA responses in twins and gnotobiotic miceNature2016534760626326627279225
   PubMed Web of Science ®Google Scholar
• LozuponeCAStombaughJIGordonJIJanssonJKKnightRDiversity, stability and resilience of the human gut microbiotaNature2012489741522023022972295
   PubMed Web of Science ®Google Scholar
• DavidLAMauriceCFCarmodyRNDiet rapidly and reproducibly alters the human gut microbiomeNature2014505748455956324336217
   PubMed Web of Science ®Google Scholar
• WuGDChenJHoffmannCLinking long-term dietary patterns with gut microbial enterotypesScience2011334605210510821885731
   PubMed Web of Science ®Google Scholar
• De FilippoCCavalieriDDi PaolaMImpact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural AfricaProcNatlAcadSci U S A2010107331469114696
   PubMed Web of Science ®Google Scholar
• DevkotaSWangYMuschMWDietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− miceNature2012487740510410822722865
   PubMed Web of Science ®Google Scholar
• AnanthakrishnanANKhaliliHHiguchiLMHigher predicted vitamin D status is associated with reduced risk of Crohn’s diseaseGastroenterology2012142348248922155183
   PubMed Web of Science ®Google Scholar
• GargMRosellaOLubelJSGibsonPRAssociation of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel diseaseInflamm Bowel Dis201319122634264324105392
   PubMed Web of Science ®Google Scholar
• BashirMPrietlBTauschmannMEffects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tractEur J Nutr20165541479148926130323
   PubMed Web of Science ®Google Scholar
• LuppCRobertsonMLWickhamMEHost-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of EnterobacteriaceaeCell Host Microbe20072211912918005726
   PubMed Web of Science ®Google Scholar
• Darfeuille-MichaudABoudeauJBuloisPHigh prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s diseaseGastroenterology2004127241242115300573
   PubMed Web of Science ®Google Scholar
• OhkusaTSatoNOgiharaTMoritaKOgawaMOkayasuIFusobacteriumvarium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibodyJ GastroenterolHepatol2002178849853
   Web of Science ®Google Scholar
• FiteAMacfarlaneSFurrieELongitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and durationJ ClinMicrobiol2013513849856
   Google Scholar
• Rajilic-StojanovicMShanahanFGuarnerFde VosWMPhylogenetic analysis of dysbiosis in ulcerative colitis during remissionInflamm Bowel Dis201319348148823385241
   PubMed Web of Science ®Google Scholar
• OttSJKuhbacherTMusfeldtMFungi and inflammatory bowel diseases: alterations of composition and diversityScand J Gastroenterol200843783184118584522
   PubMed Web of Science ®Google Scholar
• LiQWangCTangCHeQLiNLiJDysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn’s diseaseJ ClinGastroenterol2014486513523
   Web of Science ®Google Scholar
• LewisJDChenEZBaldassanoRNInflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn’sdiseaseCell Host Microbe201518448950026468751
   PubMed Web of Science ®Google Scholar
• HoarauGMukherjeePKGower-RousseauCBacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s DiseaseMBio201675 pii: e01250-16
   Web of Science ®Google Scholar
• LepagePColombetJMarteauPSime-NgandoTDoréJLeclercMDysbiosis in inflammatory bowel disease: a role for bacteriophages?Gut200857342442518268057
   PubMed Web of Science ®Google Scholar
• NormanJMHandleySABaldridgeMTDisease-specific alterations in the enteric virome in inflammatory bowel diseaseCell2015160344746025619688
   PubMed Web of Science ®Google Scholar
• SepehriSKotlowskiRBernsteinCNKrauseDOMicrobial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel diseaseInflamm Bowel Dis200713667568317262808
   PubMed Web of Science ®Google Scholar
• OguraYBonenDKInoharaNA frameshift mutation in NOD2 associated with susceptibility to Crohn’s diseaseNature2001411683760360611385577
   PubMed Web of Science ®Google Scholar
• PhilpottDJGirardinSECrohn’s disease-associated Nod2 mutants reduce IL10 transcriptionNat Immunol200910545545719381138
   PubMed Web of Science ®Google Scholar
• Petnicki-OcwiejaTHrncirTLiuYJNod2 is required for the regulation of commensal microbiota in the intestineProcNatlAcadSci U S A2009106371581315818
   PubMed Web of Science ®Google Scholar
• XavierRJMicrobiota as therapeutic targetsDig Dis201634555856527331403
   PubMed Web of Science ®Google Scholar
• IlievIDFunariVATaylorKDInteractions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitisScience201233660861314131722674328
   PubMed Web of Science ®Google Scholar
• HviidASvanstromHFrischMAntibiotic use and inflammatory bowel diseases in childhoodGut2011601495420966024
   PubMed Web of Science ®Google Scholar
• VirtaLAuvinenAHeleniusHHuovinenPKolhoKLAssociation of repeated exposure to antibiotics with the development of pediatric Crohn’s disease–a nationwide, register-based finnish case-control studyAm J Epidemiol2012175877578422366379
   PubMed Web of Science ®Google Scholar
• KronmanMPZaoutisTEHaynesKFengRCoffinSEAntibiotic exposure and IBD development among children: a population-based cohort studyPediatrics20121304e794e80323008454
   PubMed Web of Science ®Google Scholar
• UngaroRBernsteinCNGearryRAntibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: a meta-analysisAm J Gastroenterol2014109111728173825223575
   PubMed Web of Science ®Google Scholar
• Investigators IBDiESTjonnelandAOvervadKLinoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort studyGut200958121606161119628674
   PubMed Web of Science ®Google Scholar
• AnanthakrishnanANKhaliliHKonijetiGGLong-term intake of dietary fat and risk of ulcerative colitis and Crohn’s diseaseGut201463577678423828881
   PubMed Web of Science ®Google Scholar
• GhoshSDeCoffeDBrownKFish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsisPLoS One201382e5546823405155
   PubMed Web of Science ®Google Scholar
• GerasimidisKBertzMHanskeLDecline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn’s disease during enteral nutritionInflamm Bowel Dis201420586187124651582
   PubMed Web of Science ®Google Scholar
• SokolHSeksikPFuretJPLow counts of Faecalibacteriumprausnitzii in colitis microbiotaInflamm Bowel Dis20091581183118919235886
   PubMed Web of Science ®Google Scholar
• LewisJDAbreuMTDiet as a trigger or therapy for inflammatory bowel diseasesGastroenterology20171522398414.e627793606
   PubMed Web of Science ®Google Scholar
• BorrelliOCordischiLCirulliMPolymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn’s disease: a randomized controlled open-label trialClinGastroenterolHepatol200646744753
   Google Scholar
• TakagiSUtsunomiyaKKuriyamaSEffectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn’s disease: a randomized-controlled trialAliment PharmacolTher200624913331340
   Web of Science ®Google Scholar
• GroverZMuirRLewindonPExclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn’s diseaseJ Gastroenterol201449463864523636735
   PubMed Web of Science ®Google Scholar
• LeeDBaldassanoRNOtleyARComparative effectiveness of nutritional and biological therapy in North American Children with active Crohn’sdiseaseInflamm Bowel Dis20152181786179325970545
   PubMed Web of Science ®Google Scholar
• SuskindDLWahbehGCohenSAPatients perceive clinical benefit with the specific carbohydrate diet for inflammatory bowel diseaseDig Dis Sci201661113255326027638834
   PubMed Web of Science ®Google Scholar
• SuskindDLWahbehGGregoryNVendettuoliHChristieDNutritional therapy in pediatric Crohn disease: the specific carbohydrate dietJ PediatrGastroenterolNutr20145818791
   Web of Science ®Google Scholar
• CohenSAGoldBDOlivaSClinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn diseaseJ PediatrGastroenterolNutr2014594516521
   Web of Science ®Google Scholar
• ObihCWahbehGLeeDSpecific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD centerNutrition201632441842526655069
   PubMed Web of Science ®Google Scholar
• KakodkarSFarooquiAJMikolaitisSLMutluEAThe specific carbohydrate diet for inflammatory bowel disease: a case seriesJ AcadNutr Diet2015115812261232
   Web of Science ®Google Scholar
• SuskindDLCohenSABrittnacherMJClinical and fecal microbial changes with diet therapy in active inflammatory bowel diseaseJ ClinGastroenterol Epub20161227
   Google Scholar
• Sigall-BonehRPfeffer-GikTSegalIZangenTBoazMLevineAPartial enteral nutrition with a Crohn’s disease exclusion diet is effective for induction of remission in children and young adults with Crohn’s diseaseInflamm Bowel Dis20142081353136024983973
   PubMed Web of Science ®Google Scholar
• RiordanAMHunterJOCowanRETreatment of active Crohn’s disease by exclusion diet: East Anglian multicentre controlled trialLancet19933428880113111347901473
   PubMed Web of Science ®Google Scholar
• RajendranNKumarDFood-specific IgG4-guided exclusion diets improve symptoms in Crohn’s disease: a pilot studyColorectal Dis20111391009101320626437
   PubMed Web of Science ®Google Scholar
• ChibaMAbeTTsudaHLifestyle-related disease in Crohn’s disease: relapse prevention by a semi-vegetarian dietWorld J Gastroenterol201016202484249520503448
   PubMed Web of Science ®Google Scholar
• GearryRBIrvingPMBarrettJSNathanDMShepherdSJGibsonPRReduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot studyJ Crohns Colitis20093181421172242
   PubMed Web of Science ®Google Scholar
• PrinceACMyersCEJoyceTIrvingPLomerMWhelanKFermentable carbohydrate restriction (Low FODMAP Diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel diseaseInflamm Bowel Dis20162251129113626914438
   PubMed Web of Science ®Google Scholar
• HalmosEPChristophersenCTBirdARShepherdSJMuirJGGibsonPRConsistent prebiotic effect on gut microbiotawith altered FODMAP intake in patients with Crohn’sdisease: a randomised, controlled cross-over trial of well-defined dietsClinTranslGastroenterol20167e164
   Web of Science ®Google Scholar
• ZimmerJLangeBFrickJSA vegan or vegetarian diet substantially alters the human colonic faecal microbiotaEur J ClinNutr20126615360
   PubMed Web of Science ®Google Scholar
• ChassaingBKorenOGoodrichJKDietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndromeNature20155197541929625731162
   PubMed Web of Science ®Google Scholar
• NickersonKPChaninRMcDonaldCDeregulation of intestinal anti-microbial defense by the dietary additive, maltodextrinGut Microbes201561788325738413
   PubMed Web of Science ®Google Scholar
• van NoodEVriezeANieuwdorpMDuodenal infusion of donor feces for recurrent Clostridium difficileN Engl J Med2013368540741523323867
   PubMed Web of Science ®Google Scholar
• IaniroGBibboSScaldaferriFGasbarriniACammarotaGFecal microbiota transplantation in inflammatory bowel disease: beyond the excitementMedicine (Baltimore)20149319e9725340496
   PubMed Web of Science ®Google Scholar
• KumpPKGrochenigHPLacknerSAlteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitisInflamm Bowel Dis201319102155216523899544
   PubMed Web of Science ®Google Scholar
• KundeSPhamABonczykSSafety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitisJ PediatrGastroenterolNutr2013566597601
   PubMed Web of Science ®Google Scholar
• MoayyediPSuretteMGKimPTFecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trialGastroenterology20151491102109 e625857665
   PubMed Web of Science ®Google Scholar
• RossenNGFuentesSvan der SpekMJFindings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitisGastroenterology20151491110118.e425836986
   PubMed Web of Science ®Google Scholar
• CasellasFBorruelNPapoMAntiinflammatory effects of enterically coated amoxicillin-clavulanic acid in active ulcerative colitisInflamm Bowel Dis199841159552221
   PubMed Web of Science ®Google Scholar
• SelbyWPavliPCrottyBAntibiotics in Crohn’s Disease Study GroupTwo-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn’s diseaseGastroenterology200713272313231917570206
   PubMed Web of Science ®Google Scholar
• WangSLWangZRYangCQMeta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel diseaseExpTher Med20124610511056
   PubMed Web of Science ®Google Scholar
• MackDRProbiotics in inflammatory bowel diseases and associated conditionsNutrients20113224526422254095
   PubMed Web of Science ®Google Scholar
• GionchettiPRizzelloFVenturiAOral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trialGastroenterology2000119230530910930365
   PubMed Web of Science ®Google Scholar
• MimuraTRizzelloFHelwigUOnce daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitisGut200453110811414684584
   PubMed Web of Science ®Google Scholar
• MatsuokaKKanaiTThe gut microbiota and inflammatory bowel diseaseSeminImmunopathol20153714755
   PubMed Web of Science ®Google Scholar
• GuarnerFPrebiotics in inflammatory bowel diseasesBr J Nutr200798Suppl 1S85S8917922967
   PubMed Web of Science ®Google Scholar
• ArribasBSuarez-PereiraEOrtiz MelletCDi-D-fructose dianhydride-enriched caramels: effect on colon microbiota, inflammation, and tissue damage in trinitrobenzenesulfonic acid-induced colitic ratsJ Agric Food Chem201058106476648420423151
   PubMed Web of Science ®Google Scholar
• NishimuraTAndohAHashimotoTKoboriATsujikawaTFujiyamaYCellobiose prevents the development of dextran sulfate sodium (DSS)-induced experimental colitisJ ClinBiochemNutr2010462105110
   Web of Science ®Google Scholar
• BenjaminJLHedinCRKoutsoumpasARandomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn’s diseaseGut201160792392921262918
   PubMed Web of Science ®Google Scholar
• KimSKimJHParkBOKwakYSPerspectives on the therapeutic potential of short-chain fatty acid receptorsBMB Rep201447317317824499669
   PubMed Web of Science ®Google Scholar
• AtarashiKTanoueTShimaTInduction of colonic regulatory T cells by indigenous Clostridium speciesScience2011331601533734121205640
   PubMed Web of Science ®Google Scholar
• SmithPMHowittMRPanikovNThe microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasisScience2013341614556957323828891
   PubMed Web of Science ®Google Scholar
• Huda-FaujanNAbdulamirASFatimahABThe impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjectsOpen Biochem J20104535820563285
   PubMedGoogle Scholar
• KolevaPTValchevaRSSunXGänzleMGDielemanLAInulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic ratsBr J Nutr201210891633164322243836
   PubMed Web of Science ®Google Scholar
• JooEYamaneSHamasakiAEnteral supplement enriched with glutamine, fiber, and oligosaccharide attenuates experimental colitis in miceNutrition201329354955523274091
   PubMed Web of Science ®Google Scholar
• BrothertonCSMartinCALongMDKappelmanMDSandlerRSAvoidance of fiber is associated with greater risk of Crohn’s disease flare in a 6-month periodClin Gastroenterol Hepatol20161481130113626748217
   PubMed Web of Science ®Google Scholar